WASHINGTON, D.C. – A new report released today by the Sabin-Aspen Vaccine Science & Policy Group, a joint initiative of the Sabin Vaccine Institute and the Aspen Institute, calls for an urgent, coordinated effort to amplify and focus resources on the long-sought, but overdue achievement of a universal influenza vaccine (UIV).
Statements and Press Releases
Washington, D.C. – The Sabin Vaccine Institute (Sabin) today announced it will present its annual Albert B. Sabin Gold Medal to Dr. Carol J. Baker, whose groundbreaking research in Group B Streptococcus (GBS) is accelerating progress toward a much-needed vaccine to prevent a bacterial infection that can cause lifelong illness or death in newborns.
HANOI, VIETNAM – Beginning today, the 11th International Conference on Typhoid and Other Invasive Salmonelloses brings together more than 450 researchers, policy makers and advocates who are dedicated to improving the lives of young children and their families suffering from typhoid, paratyphoid and invasive non-typhoidal Salmonella.
WASHINGTON, D.C. – Today, the Senate Health, Education, Labor, and Pensions (HELP) Committee conducted a hearing on rising rates of vaccine hesitancy causing preventable disease outbreaks across the country – such as the ongoing outbreaks in Washington, Illinois, and New York.